EOG
54
9
SLB
46
-2
TROW
56
-2
SPG
51
-5
SHW
50
-3
ISRG
69
-2
GRMN
42
-3
BMY
69
-2
SRE
54
-3
GOOGL
50
-17
AEE
58
-2
FLS
61
-4
LB
33
-7
VRSK
23
-7
EIX
45
-8
NSC
60
-2
BAX
41
-3
TSN
43
-3
EXC
50
-3
V
36
-8
EOG
54
9
SLB
46
-2
TROW
56
-2
SPG
51
-5
SHW
50
-3
ISRG
69
-2
GRMN
42
-3
BMY
69
-2
SRE
54
-3
GOOGL
50
-17
AEE
58
-2
FLS
61
-4
LB
33
-7
VRSK
23
-7
EIX
45
-8
NSC
60
-2
BAX
41
-3
TSN
43
-3
EXC
50
-3
V
36
-8
Financhill
Back

Apellis Pharmaceuticals, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
54

APLS
Apellis Pharmaceuticals, Inc.

Last Price:
$23.80
Seasonality Move:
12.69%
Buy
90

KYMR
Kymera Therapeutics, Inc.

Last Price:
$94.38
Seasonality Move:
7.7%
Buy
54
Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals, Inc. [APLS] share price is $23.79. The Score for APLS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
90
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals, Inc.'s stock price today?

  • The Apellis Pharmaceuticals, Inc. share price today is $23.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $94.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 62.23 Buy
Chaikin Money Flow: -1539673 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.35 - 21.77) Buy
Bollinger Bands (100): (20.52 - 26.86) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 86.88 Buy
Chaikin Money Flow: -462379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.8 - 71.72) Buy
Bollinger Bands (100): (43.38 - 63.26) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.95 Buy
20-day SMA: 20.69 Buy
50-day SMA: 22.96 Buy
200-day SMA: 21.97 Buy
8-day EMA: 22.17 Buy
20-day EMA: 21.64 Buy
50-day EMA: 22.39 Buy
200-day EMA: 24.23 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70 Buy
20-day SMA: 66.61 Buy
50-day SMA: 61.97 Buy
200-day SMA: 44.25 Buy
8-day EMA: 72.36 Buy
20-day EMA: 67.57 Buy
50-day EMA: 61.93 Buy
200-day EMA: 49.42 Buy

Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

Apellis Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):